abacavir, dolutegravir and lamivudine film coated tablets
laurus labs limited, india - abacavir, dolutegravir , lamivudine - film coated tablets - 600/50/300
abacavir lamivudine taro
taro international ltd, israel - abacavir; lamivudine - film coated tablets - lamivudine 300 mg; abacavir 600 mg - lamivudine and abacavir - abacavir lamivudine taro is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults, adolescents and children weighing at least 25 kg.
abacavir sulphate/dolutegravir sodium/lamivudine tablets
laurus labs limited, india - abacavir, dolutegravir, lamivudine - tablets - 600/50/300 mg
abacavir, dolutegravir and lamivudine tablets 600mg/50mg/300mg 600/50/300
hetero laboratories limited, india - abacavir, dolutegravir , lamivudine tablets 600mg/50mg/300mg - tablets - 600/50/300
ziagen tablets
glaxo smith kline (israel) ltd - abacavir as sulfate - film coated tablets - abacavir as sulfate 300 mg - abacavir - abacavir - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infected .28/10/2018 בקשה לשינוי משטר מינון
abacavir tablet
strides pharma science limited - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - abacavir 300 - abacavir tablets in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (hiv-1) infection. abacavir tablets are contraindicated in patients: - who have the hla-b*5701 allele [see warnings and precautions (5.1)]. - with prior hypersensitivity reaction to abacavir [see warnings and precautions (5.1)]. - with moderate or severe hepatic impairment [see use in specific populations (8.6)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abacavir tablets during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary available data from the apr show no difference in the overall risk of birth defects for abacavir compared with the background rate for birth defects of 2.7% in the metropolitan atlanta congenital defects program (macdp) reference population (see data). the apr uses the macdp as
abacavir tablet, film coated
cipla usa inc. - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - abacavir 300 mg - abacavir tablets usp 300 mg, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (hiv-1) infection. abacavir tablet is contraindicated in patients: - who have the hla-b*5701 allele [see warnings and precautions (5.1)] . - with prior hypersensitivity reaction to abacavir [see warnings and precautions (5.1)] . - with moderate or severe hepatic impairment [see use in specific populations (8.6)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abacavir sulfate during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary available data from the apr show no difference in the overall risk of birth defects for abacavir compared with the background rate for birth defects of 2.7% in the metropolitan atlanta congenital defects program (macdp) reference population (see dat
ziagen tablets
glaxo smith kline (israel) ltd - abacavir as sulfate - film coated tablets - abacavir as sulfate 300 mg - abacavir - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infected .
abacavir, dolutegravir and lamivudine tablets 600 mg + 50 mg + 300 mg oral solid ordinary film-coated tablets
laurus labs limited - - abacavir sulfate + dolutegravir sodium + lamivudine - oral solid ordinary film-coated tablets - 600 mg + 50 mg + 300 mg
abacavir accord 300 mg film-coated tablets
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - abacavir - film-coated tablet - abacavir 300 mg - antivirals for systemic use